Fludarabine is a chemotherapeutic agent used in the treatment of hematological malignancies. It is commonly marketed under the brand name Fludara.
For the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States
UT MD Anderson Cancer Center, Houston, Texas, United States
Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado, United States
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
UT MD Anderson Cancer Center, Houston, Texas, United States
ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE, Lecce, Italy
Ospedale Regionale A. Pugliese, Catanzaro, Italy
Universita di Ferrara, Ferrara, Italy
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Queen's Hospital, Burton-upon-Trent, England, United Kingdom
Basingstoke and North Hampshire NHS Foundation Trust, Basingstoke, England, United Kingdom
Hereford Hospitals, Hereford, United Kingdom
Children's Hospital and Research Center at Oakland, Oakland, California, United States
Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
University of California-San Diego, La Jolla, California, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.